Skip to main content
Log in

Bevacizumab/ranibizumab

Acute kidney injury: 2 case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Georgalas I, et al. Renal Injury Following Intravitreal Anti-VEGF Administration in Diabetic Patients with Proliferative Diabetic Retinopathy and Chronic Kidney Disease - A Possible Side Effect? Current Drug Safety 9: 156-158, No. 2, 2014 - Greece

    CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab/ranibizumab. Reactions Weekly 1515, 46 (2014). https://doi.org/10.1007/s40278-014-2741-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-2741-1

Navigation